Atlas Trials

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Clinical trial NCT00277810 · COMPLETED

Trial details

NCT number
NCT00277810
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2006-03-01
Primary completion
2008-06-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.